Breaking News Instant updates and real-time market news.

WLK

Westlake Chemical

$106.62

-0.575 (-0.54%)

, MTD

Mettler-Toledo

$558.45

3.19 (0.57%)

10:34
04/09/18
04/09
10:34
04/09/18
10:34

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Westlake Chemical (WLK) downgraded to Neutral from Overweight at JPMorgan with analyst Jeffrey Zekauskas citing valuation. 2. Mettler-Toledo (MTD) downgraded to Neutral from Buy at Goldman Sachs with analyst Patrick Donnelly saying he sees an attractive fundamental backdrop across Tools but is more cautious on the outlook for sales upside at Mettler given his view of a likely moderation of growth in China after a year of catch-up investment in the region. Donnelly also highlights "tough comps" in Labs and Product inspection. 3. Franklin Resources (BEN) downgraded to Neutral from Buy at BofA/Merrill with analyst Michael Carrier saying Franklin's bottom half performance and continued outflows limits organic growth and multiple expansion. 4. NewLink Genetics (NLNK) downgraded to Neutral from Overweight at Cantor Fitzgerald and Baird as well as to Hold from Buy at Jefferies. 5. Incyte (INCY) downgraded to Hold from Buy at Gabelli with analyst Jing He citing the "surprising" failure of the Phase 3 ECHO-301 study in melanoma. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

WLK

Westlake Chemical

$106.62

-0.575 (-0.54%)

MTD

Mettler-Toledo

$558.45

3.19 (0.57%)

BEN

Franklin Resources

$33.12

-0.1 (-0.30%)

NLNK

NewLink Genetics

$4.20

-3.12 (-42.62%)

INCY

Incyte

$64.02

-19.05 (-22.93%)

  • 23

    Apr

  • 08

    May

  • 12

    Jun

WLK Westlake Chemical
$106.62

-0.575 (-0.54%)

02/21/18
SBSH
02/21/18
NO CHANGE
Target $133
SBSH
Buy
Westlake Chemical price target raised to $133 from $125 at Citi
Citi analyst P.J. Juvekar raised his price target for Westlake Chemical to $133 citing the upcycles in chlor alkali and vinyls. Vinyls continues on an upward trajectory helped by an improving chlor alkali cycle, chlorine capacity shutdowns in Europe, China environmental regulations and improved utilization of the acquired Axiall assets, Juvekar tells investors in a research note. The analyst reiterates a Buy rating on Westlake.
03/27/18
BMOC
03/27/18
INITIATION
Target $125
BMOC
Market Perform
Westlake Chemical initiated with a Market Perform at BMO Capital
BMO Capital analyst John McNulty started Westlake Chemical with a Market Perform rating and $125 price target.
03/28/18
BMOC
03/28/18
INITIATION
Target $125
BMOC
Market Perform
Westlake Chemical initiated with a Market Perform at BMO Capital
As reported earlier, BMO Capital analyst John McNulty initiated Westlake Chemical with a Market Perform rating and a price target of $125. McNulty says the company offers an opportunity to invest in the current Chlor-Alkali upcycle, adding that he is also positive on Westlake's integrated nature of Olefins and Vinyls business segments. Based on the early 2018 outperformance, McNulty states that he has a more cautious near-term approach on the stock.
04/09/18
JPMS
04/09/18
DOWNGRADE
Target $110
JPMS
Neutral
Westlake Chemical downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded Westlake Chemical to Neutral while raising his price target for the shares to $110 from $104. The analyst cites valuation for the downgrade and believes new ethylene and polyethylene capacity is likely slow EBITDA growth and bring margin pressure. He does not see Westlake shares outperforming over the next year.
MTD Mettler-Toledo
$558.45

3.19 (0.57%)

04/09/18
GSCO
04/09/18
UPGRADE
Target $77
GSCO
Buy
Goldman upgrades Agilent to Buy ahead of Q1 earnings season
Goldman Sachs analyst Patrick Donnelly upgraded Agilent Technologies (A) to Buy from Neutral and raised his price target for the shares to $77 from $73. Heading into the Q1 earnings season, the analyst sees an attractive fundamental backdrop across Tools. He believes, however, that the favorable backdrop is well understood by investors with valuations that "remain well-above 10-year highs." The analyst prefers the "idiosyncratic drivers of growth" for Agilent in the out years and views the stock's relative valuation as attractive. He coupled the upgrade with a downgrade of Mettler-Toledo (MTD) to Neutral.
04/09/18
GSCO
04/09/18
DOWNGRADE
Target $600
GSCO
Neutral
Goldman downgrades Mettler-Toledo to Neutral ahead of Q1 earnings
Goldman Sachs analyst Patrick Donnelly downgraded Mettler-Toledo (MTD) to Neutral from Buy and cut his price target for the shares to $600 from $725. Heading into the Q1 earnings season, the analyst sees an attractive fundamental backdrop across Tools. He believes, however, that the favorable backdrop is well understood by investors with valuations that "remain well-above 10-year highs." The analyst is more cautious on the outlook for sales upside at Mettler given his view of a likely moderation of growth in China after a year of catch-up investment in the region. Donnelly also highlights "tough comps" in Labs and Product inspection. He coupled the downgrade with an upgrade of Agilent Technologies (A) to Buy.
04/09/18
GSCO
04/09/18
DOWNGRADE
GSCO
Neutral
Mettler-Toledo downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Patrick Donnell downgraded Mettler-Toledo to Neutral.
02/09/18
SBSH
02/09/18
UPGRADE
Target $692
SBSH
Buy
Mettler-Toledo upgraded to Buy from Neutral at Citi
Citi analyst Daniel Arias upgraded Mettler-Toledo to Buy and raised his price target for the shares to $692 from $685. The recent 13% selloff provides an opportunity to own a "best-in-class franchise with an excellent performance track record and relatively few business-related flaws," Arias tells investors in a research note. He expects the company's momentum in Q4 to carry into 2018.
BEN Franklin Resources
$33.12

-0.1 (-0.30%)

04/09/18
BOFA
04/09/18
DOWNGRADE
BOFA
Neutral
Franklin Resources downgraded to Neutral on weak performance at BofA/Merrill
As previously reported, As previously reported, BofA/Merrill downgraded Franklin Resources to Neutral from Buy and cut its price target to $37 from $50. Analyst Michael Carrier believes Franklin's bottom half performance and continued outflows limits organic growth and multiple expansion. Carrier lowered estimates given weaker Q1 markets, increased outflow expectations, and more muted 2018 return expectations.
04/09/18
BOFA
04/09/18
DOWNGRADE
BOFA
Neutral
Franklin Resources downgraded to Neutral from Buy at BofA/Merrill
04/05/18
FBCO
04/05/18
NO CHANGE
Target $34
FBCO
Underperform
Franklin Resources price target lowered to $34 from $39.57 at Credit Suisse
Credit Suisse analyst Craig Siegenthaler lowered his price target for Franklin Resources to $34 from $57 on valuation. The analyst reiterates an Underperform rating on the shares.
09/08/17
LEHM
09/08/17
INITIATION
Target $40
LEHM
Underweight
Franklin Resources initiated with an Underweight at Barclays
Barclays analyst Jeremy Campbell started Franklin Resources with an Underweight rating and $40 price target. The analyst initiated U.S. Brokers, Asset Managers & Exchanges with a Neutral industry view.
NLNK NewLink Genetics
$4.20

-3.12 (-42.62%)

04/09/18
RHCO
04/09/18
DOWNGRADE
Target $5
RHCO
Hold
NewLink Genetics downgraded to Hold at SunTrust on Incyte trial failure
As reported late last week, SunTrust analyst Peter Lawson downgraded NewLink Genetics (NLNK) to Hold from Buy and lowered his price target to $5 from $19. Lawson cites the announcement of negative results from the Phase 3 ECHO-301 of epacadostat + Keytruda in melanoma by Incyte (INCY), saying the data also implies a "significant negative read through for NewLink's IDO agent, indoximod". Lawson adds that the results have led him to remove melanoma from his NewLink model and also reduce the probability of success in pancreatic cancer, lowering the probability of adjusted peak sales from $415M to just $11M.
04/09/18
CANT
04/09/18
DOWNGRADE
CANT
Neutral
NewLink Genetics downgraded to Neutral from Overweight at Cantor Fitzgerald
04/09/18
BARD
04/09/18
DOWNGRADE
Target $5
BARD
Neutral
NewLink Genetics downgraded to Neutral at Baird
As reported previously, Baird analyst Michael Ulz downgraded NewLink Genetics (NLNK) to Neutral from Outperform. The analyst cited the disappointing results from Incyte's (INCY) Phase-3 ECHO-301 study in melanoma. Given the uncertainty surrounding the opportunity after NewLink said it will revisit the indoximod clinical program following Incyte's news, Ulz lowered his price target to $5 from $22 on NewLink Genetics shares.
04/09/18
CANT
04/09/18
DOWNGRADE
Target $7
CANT
Neutral
Cantor downgrades NewLink with $7 target on added indoximod uncertainty
Cantor Fitzgerald analyst Mara Goldstein downgraded NewLink Genetics (NLNK) to Neutral from Overweight and cut her price target for the shares to $7 from $26. The analyst cites NewLink's decision to revisit the indoximod clinical program as the reason for the downgrade. Goldstein previously highlighted the differentiating factors between indoximod and Incyte's (INCY) epacadostat, but she now has reduced confidence given a "lack of decisive commentary" from NewLink management.
INCY Incyte
$64.02

-19.05 (-22.93%)

04/09/18
GABE
04/09/18
DOWNGRADE
GABE
Hold
Incyte downgraded to Hold from Buy at Gabelli
Gabelli analyst Jing He downgraded Incyte to Hold following the "surprising" failure of the Phase 3 ECHO-301 study in melanoma. The analyst remains positive on Jakafi's long-term growth and estimates peak sales of $2.7B but recommends staying on the sideline before baricitinib Adcom on April 23.
04/09/18
FBCO
04/09/18
NO CHANGE
Target $78
FBCO
Outperform
Incyte price target lowered to $78 from $145 at Credit Suisse
Credit Suisse analyst Alethia Young lowered her price target for Incyte to $78 from $145 following news on ECHO-301 and as she removes epacadostat from valuation. The analyst reiterates an Outperform rating on the shares.
04/09/18
RHCO
04/09/18
NO CHANGE
Target $80
RHCO
Buy
Incyte price target lowered to $80 from $155 at SunTrust
SunTrust analyst Peter Lawson slashed his price target on Incyte to $80 after the failure of phase 3 IDO study in melanoma, saying that he is removing all IDO indicators from his model while also sharply discounting the post-IDO pipeline. While the analyst warns that further negative news related to IDO readouts could be coming, the post-failure stock price decline does create some "underlying value", keeping his Buy rating on Incyte.

TODAY'S FREE FLY STORIES

VIX

Volatility Index S&P 500 Options

16:20
04/20/18
04/20
16:20
04/20/18
16:20
Options
Closing CBOE SPX and VIX Index summary for April 20th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRK

Park National

$105.24

-0.49 (-0.46%)

16:17
04/20/18
04/20
16:17
04/20/18
16:17
Hot Stocks
Park National raises quarterly dividend to 96c per share from 94c »

Park National's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRK

Park National

$105.24

-0.49 (-0.46%)

16:17
04/20/18
04/20
16:17
04/20/18
16:17
Earnings
Breaking Earnings news story on Park National »

Park National reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

16:17
04/20/18
04/20
16:17
04/20/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRMB

Trimble

$36.57

-0.16 (-0.44%)

16:16
04/20/18
04/20
16:16
04/20/18
16:16
Hot Stocks
Trimble acquires assets of FabSuite, terms not disclosed »

Trimble announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

16:16
04/20/18
04/20
16:16
04/20/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$111.69

0.56 (0.50%)

16:15
04/20/18
04/20
16:15
04/20/18
16:15
Hot Stocks
Celanese names Benita Casey chief accounting officer »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 30

    May

SSW

Seaspan

$7.75

0.725 (10.32%)

16:15
04/20/18
04/20
16:15
04/20/18
16:15
Hot Stocks
Seaspan COO/General Counsel Mark Chu steps down »

Seaspan Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

HON

Honeywell

$150.52

2.165 (1.46%)

, GE

General Electric

$14.54

0.55 (3.93%)

16:15
04/20/18
04/20
16:15
04/20/18
16:15
General news
On The Fly: Top stock stories for Friday »

Stocks opened little…

HON

Honeywell

$150.52

2.165 (1.46%)

GE

General Electric

$14.54

0.55 (3.93%)

AAPL

Apple

$165.71

-7.08 (-4.10%)

WFC

Wells Fargo

$52.57

1.02 (1.98%)

AGN

Allergan

$158.48

-0.11 (-0.07%)

WAB

Wabtec

$87.54

3.8 (4.54%)

SHPG

Shire

$164.43

3.63 (2.26%)

TKPYY

Takeda Pharmaceutical

MAT

Mattel

$12.95

-0.49 (-3.65%)

TSM

TSMC

$38.96

-0.57 (-1.44%)

PF

Pinnacle Foods

$60.58

5.38 (9.75%)

LLNW

Limelight Networks

$4.99

0.89 (21.71%)

TRU

TransUnion

$66.84

6.33 (10.46%)

CHD

Church & Dwight

$45.90

-2.82 (-5.79%)

CLW

Clearwater Paper

$26.90

-13.55 (-33.50%)

SKX

Skechers

$30.70

-11.3903 (-27.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 20

    Apr

  • 20

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 26

    Apr

  • 27

    Apr

  • 30

    Apr

  • 01

    May

  • 03

    May

  • 03

    May

  • 03

    May

  • 08

    May

  • 15

    May

  • 23

    May

  • 30

    May

  • 12

    Jun

  • 25

    Jun

  • 21

    Dec

WASH

Washington Trust

$56.35

0.45 (0.81%)

16:08
04/20/18
04/20
16:08
04/20/18
16:08
Earnings
Washington Trust reports Q1 adjusted EPS 93c, consensus 87c »

Q1 Returns on average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 14

    May

INVE

Identiv

$3.54

0.03 (0.85%)

16:05
04/20/18
04/20
16:05
04/20/18
16:05
Syndicate
Breaking Syndicate news story on Identiv »

Identiv files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

AA

Alcoa

$59.78

-0.47 (-0.78%)

, AAL

American Airlines

$46.58

-0.3 (-0.64%)

16:02
04/20/18
04/20
16:02
04/20/18
16:02
Periodicals
Breaking Periodicals news story on Alcoa, American Airlines, Alaska Air, Boeing, Delta Air Lines, General Electric, Southwest, United Continental, JetBlue »

FAA to prepare emergency…

AA

Alcoa

$59.78

-0.47 (-0.78%)

AAL

American Airlines

$46.58

-0.3 (-0.64%)

ALK

Alaska Air

$65.41

-0.14 (-0.21%)

BA

Boeing

$337.30

-3.25 (-0.95%)

DAL

Delta Air Lines

$55.33

0.27 (0.49%)

GE

General Electric

$14.65

0.655 (4.68%)

LUV

Southwest

$54.64

-0.14 (-0.26%)

UAL

United Continental

$71.73

1.485 (2.11%)

JBLU

JetBlue

$19.83

0.17 (0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 23

    Apr

  • 24

    Apr

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 09

    May

  • 10

    May

  • 29

    May

  • 30

    May

  • 26

    Jun

  • 29

    Jun

PSX

Phillips 66

$110.85

0.23 (0.21%)

15:55
04/20/18
04/20
15:55
04/20/18
15:55
Options
Phillips 66 put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

ULTI

Ultimate Software

$244.01

-4.76 (-1.91%)

15:51
04/20/18
04/20
15:51
04/20/18
15:51
Hot Stocks
Ultimate Software announces SMS Equipment to use its reporting product »

Ultimate Software…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 12

    Jun

C

Citi

$69.85

-0.43 (-0.61%)

, USB

U.S. Bancorp

$50.24

-0.45 (-0.89%)

15:49
04/20/18
04/20
15:49
04/20/18
15:49
Periodicals
Big U.S. banks race to launch mortgage apps as home lending slows, Reuters says »

Large U.S. banks are…

C

Citi

$69.85

-0.43 (-0.61%)

USB

U.S. Bancorp

$50.24

-0.45 (-0.89%)

JPM

JPMorgan

$111.07

-0.66 (-0.59%)

BAC

Bank of America

$30.19

-0.015 (-0.05%)

GS

Goldman Sachs

$251.52

-2.67 (-1.05%)

WFC

Wells Fargo

$52.49

0.94 (1.82%)

MS

Morgan Stanley

$54.11

-0.58 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 26

    Apr

  • 02

    May

  • 15

    May

  • 16

    May

  • 23

    May

  • 30

    May

  • 06

    Jun

  • 13

    Jul

  • 12

    Oct

T

AT&T

$34.67

-0.15 (-0.43%)

, VZ

Verizon

$48.01

-0.43 (-0.89%)

15:46
04/20/18
04/20
15:46
04/20/18
15:46
Periodicals
U.S. investigating wireless collusion claim against AT&T, Verizon, NY Times says »

The U.S. Department of…

T

AT&T

$34.67

-0.15 (-0.43%)

VZ

Verizon

$48.01

-0.43 (-0.89%)

S

Sprint

$6.00

0.045 (0.76%)

TMUS

T-Mobile

$63.28

0.02 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 09

    May

HPE

HP Enterprise

$17.23

-0.19 (-1.09%)

15:45
04/20/18
04/20
15:45
04/20/18
15:45
Options
Hewlett Packard Enterprise call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 11

    Jun

T

AT&T

$34.64

-0.18 (-0.52%)

, VZ

Verizon

$47.99

-0.45 (-0.93%)

15:42
04/20/18
04/20
15:42
04/20/18
15:42
Periodicals
Breaking Periodicals news story on AT&T, Verizon, Sprint, T-Mobile »

U.S. investigating…

T

AT&T

$34.64

-0.18 (-0.52%)

VZ

Verizon

$47.99

-0.45 (-0.93%)

S

Sprint

$6.00

0.045 (0.76%)

TMUS

T-Mobile

$63.27

0.01 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 09

    May

ALXN

Alexion

$106.59

-5.15 (-4.61%)

15:36
04/20/18
04/20
15:36
04/20/18
15:36
Hot Stocks
Alexion says no licence of Soliris was requested or granted in Brazil »

Recent media reports have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

SYNT

Syntel

$28.04

0.19 (0.68%)

15:35
04/20/18
04/20
15:35
04/20/18
15:35
Recommendations
Syntel analyst commentary  »

Syntel's rest of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

TRUP

Trupanion

$27.51

-1.42 (-4.91%)

15:35
04/20/18
04/20
15:35
04/20/18
15:35
Periodicals
Trupanion cost saving sharing may violate state laws, Capitol Forum says »

Insurance experts and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 10

    May

BURL

Burlington Stores

$132.82

-3.36 (-2.47%)

15:30
04/20/18
04/20
15:30
04/20/18
15:30
Options
Bullish option play in Burlington Stores as shares slump »

Bullish option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIA

Viacom

$35.35

-0.25 (-0.70%)

, FOXA

21st Century Fox

$36.69

-0.51 (-1.37%)

15:29
04/20/18
04/20
15:29
04/20/18
15:29
Hot Stocks
Box Office Battle: 'A Quiet Place' expected to creep back into top spot »

Expected to return to the…

VIA

Viacom

$35.35

-0.25 (-0.70%)

FOXA

21st Century Fox

$36.69

-0.51 (-1.37%)

LGF.B

Lionsgate

$23.89

-0.55 (-2.25%)

VIAB

Viacom

$30.77

0.02 (0.07%)

CMCSA

Comcast

$33.14

-0.35 (-1.05%)

CMCSK

Comcast

LGF.A

Lionsgate

$25.72

-0.48 (-1.83%)

TWX

Time Warner

$95.98

-0.59 (-0.61%)

DIS

Disney

$100.01

-0.87 (-0.86%)

SNE

Sony

$49.70

-0.03 (-0.06%)

FOX

21st Century Fox

$36.12

-0.55 (-1.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 08

    May

  • 09

    May

  • 09

    May

ALXN

Alexion

$106.37

-5.37 (-4.81%)

15:28
04/20/18
04/20
15:28
04/20/18
15:28
Recommendations
Alexion analyst commentary  »

Alexion shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

ANF

Abercrombie & Fitch

$26.36

-1.08 (-3.94%)

15:25
04/20/18
04/20
15:25
04/20/18
15:25
Options
Abercrombie & Fitch call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 12

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.